Selective D1 or D2 receptor blockade. Effects on brain functional responses to L-dopa.
Ricchieri
G L
GL
Department of Neurology, University of Padua, Italy.
Pizzolato
G
G
Fabbri
M
M
Ruggero
S
S
Dam
M
M
Battistin
L
L
D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism*; D001921:Brain / Q000187:drug effects* / Q000502:physiology; D001931:Brain Mapping; D003847:Deoxyglucose / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D065127:Dopamine D2 Receptor Antagonists; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D017447:Receptors, Dopamine D1 / Q000037:antagonists & inhibitors* / Q000502:physiology; D017448:Receptors, Dopamine D2 / Q000502:physiology; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology; D013469:Sulpiride / Q000494:pharmacology
D001552:Benzazepines; D001786:Blood Glucose; D065127:Dopamine D2 Receptor Antagonists; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D007980:Levodopa; D013469:Sulpiride; D003847:Deoxyglucose; D004298:Dopamine